成年人抑郁症的治疗:系统性审查的证据和差距地图
Liping Guo1,2,3, Junjie Ren2,3, Zhipeng Wei1,2,3
1Evidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
Journal of evidence-based medicine
|March 14, 2025
概括
这项研究对成人抑郁症治疗的证据进行了映射,发现了针对特定人群和干预措施的研究缺陷. 对量身定制的治疗方法和潜在的副作用需要更多的研究.
科学领域:
- 心理健康研究 心理健康研究
- 证据综合 证据综合
- 临床心理学 临床心理学
背景情况:
- 抑郁症严重影响全球成年人群.
- 有效的治疗策略对于管理抑郁症至关重要.
- 需要对现有证据进行全面的概述,以指导未来的研究和临床实践.
研究的目的:
- 系统地识别和绘制有关成人抑郁症各种治疗方法有效性的现有系统评价.
- 使用交互式地图可视化证据景观,突出介绍干预-结果关系.
- 识别有关抑郁症治疗的现有证据中存在的空白.
主要方法:
- 从多个数据库 (英语和中文) 系统地检索随机对照试验的系统审查和元分析.
- 包括对患有抑郁症状的成年人的研究,包括心理治疗,药物治疗和补充/替代治疗.
- 开发一个证据和差距地图 (EGM),以可视化干预结果的有效性,并确定研究差距.
主要成果:
- 包括994个系统审查和元分析,详细说明主要治疗类别的分布.
- 证据和差距地图揭示了针对特定干预措施,人群 (例如,双极性抑郁症,耐治疗抑郁症,服务不足的群体),结果和地区的研究存在重大差距.
- 确定需要对药理和非药理抑郁症治疗的风险和副作用进行更多研究.
结论:
- 这种证据和差距地图提供了对成人抑郁症治疗的全面概述,为政策和实践提供了信息.
- 在干预,结果,人口和地理区域中发现了关键证据差距.
- 进一步研究专注于针对特定人群的量身定制治疗和更好地了解与治疗相关的风险是必不可少的.
相关概念视频
Depression: Overview
205
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
205
Antidepressant Drugs: Overview
344
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
344
Antidepressant Drugs: MAOIs and Other Agents
174
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
174
Diagnostic and Statistical Manual of Mental Disorders (DSM)
35
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
35
Depressive Disorders: MDD and Dysthymia
28
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
28
Depressive Disorders: Etiology
26
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
26


